Stock Analysis·← Pickers

ABT

Abbott Laboratories Common Stock

Abbott Laboratories Common Stock (ABT) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 43.0, with 1/3 trend checks passing.

Price
$89.27
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
43.0
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

ABT with MA50 and MA200

136.6123.1109.696.0882.5607/3110/2401/2204/1707/15
ABT2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$89.16+0.12% vs price
MA200
$110.17-18.97% vs price
RSI (14)
43.0Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for ABT

Abbott Laboratories Common Stock (ABT) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $89.27, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 0.1% and below the 200-day moving average by 19.0%.

Momentum and stretch context

ABT currently has an RSI reading of 43.0, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

This page is designed to help you quickly understand what the ABT chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford
Employees
114,000
Market cap
$155.49B
Beta
0.61
52-week range
$81.97 – $137.49
Dividend
Yes · $2.48
Exchange
NYSE
Country
US
IPO date
17 Mar 1980
ISIN
US0028241000
CUSIP
002824100
Website
abbott.com
Company profile data from Financial Modeling Prep. ABT listed on NYSE.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about ABT

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.